CELLDEX THERAPEUTICS INC (CLDX)

US15117B2025 - Common Stock

39.35  +1.93 (+5.16%)

After market: 39.35 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.88M2.36M4.65M7.42M3.57M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
148.93M102.59M72.39M52.77M56.80M
Research and Development
118.01M82.26M53.31M42.53M42.67M
Selling, General, and Administrative Expenses
30.91M27.20M20.49M14.46M15.43M
Operating Income
-142.04M-100.23M-67.74M-45.35M-53.23M
Interest Income/Expense
13.11M2.91M510.00K2.41M4.15M
Non Recurring Items
-12.50M-15.00M-3.50M-18.00M-1.80M
Income Before Taxes
-141.43M-112.33M-70.74M-60.95M-50.88M
Income Tax
0.000.00-230.00K-1.17M0.00
Net Income
-141.43M-112.33M-70.51M-59.78M-50.88M
EBITDA
-139.03M-97.33M-64.67M-41.42M-48.37M
 
Per Share Data
EPS Diluted Total Ops
-2.92-2.40-1.64-2.02-3.51
Non GAAP EPS
-2.91-2.21-1.64-2.14-3.63
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-2054.76%-4759.75%-1516.34%-805.66%-1425.21%
Operating Profit Margin
-2063.66%-4247.03%-1456.77%-611.19%-1491.04%

All data in USD

Charts